Sanofi (OTCMKTS:SNYNF) Shares Down 1.2% – Should You Sell?

Sanofi (OTCMKTS:SNYNF – Get Free Report)’s share price traded down 1.2% on Monday . The stock traded as low as $86.67 and last traded at $86.67. 416 shares traded hands during trading, a decline of 98% from the average session volume of 21,701 shares. The stock had previously closed at $87.71.

Sanofi Stock Performance

The firm’s 50-day moving average price is $90.16 and its two-hundred day moving average price is $92.91.

Sanofi Company Profile

(Get Free Report)

Sanofi is a multinational biopharmaceutical company headquartered in Paris, France, specializing in the research, development and manufacturing of prescription medicines, vaccines and consumer healthcare products. With a strategic focus on specialty care, vaccines, and general medicines, Sanofi’s portfolio addresses a broad range of therapeutic areas, including diabetes, cardiovascular disease, oncology, immunology and rare diseases. The company operates through distinct business segments, each dedicated to advancing patient care through innovative therapies and preventive solutions.

In its pharmaceuticals segment, Sanofi develops and markets biologics and small molecules designed to treat chronic and acute conditions.

Further Reading

• Five stocks we like better than Sanofi
• Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
• This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
• Intel Is the Market’s Most Mispriced AI Hedge
• The Biggest Opportunity From SpaceX’s IPO May Surprise You